FDA Regulation of Cannabidiol (CBD) Consumer Products: Overview and Considerations for Congress Agata Dabrowska, Coordinator Analyst in Health Policy Victoria R. Green Analyst in Health Policy Rene Johnson Specialist in Agricultural Policy Lisa N. Sacco Analyst in Illicit Drugs and Crime Policy January 21, 2020 Congressional Research Service 7-. www.crs.gov R46189